These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2849850)

  • 21. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome.
    Gorard DA; Libby GW; Farthing MJ
    Aliment Pharmacol Ther; 1994 Apr; 8(2):159-66. PubMed ID: 8038347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome.
    Bassotti G; Chistolini F; Marinozzi G; Morelli A
    Digestion; 2003; 68(4):178-83. PubMed ID: 14671425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral pinaverium bromide on colonic response to food in irritable bowel syndrome patients.
    Bouchoucha M; Faye A; Devroede G; Arsac M
    Biomed Pharmacother; 2000 Aug; 54(7):381-7. PubMed ID: 10989977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Motility of the large intestine: from irritable colon to obstipation].
    Meyer-Wyss B
    Ther Umsch; 1991 Jul; 48(7):488-93. PubMed ID: 1926009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a kefir supplement on symptoms, colonic transit, and bowel satisfaction score in patients with chronic constipation: a pilot study.
    Turan İ; Dedeli Ö; Bor S; İlter T
    Turk J Gastroenterol; 2014 Dec; 25(6):650-6. PubMed ID: 25599776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients.
    Castillejo G; Bulló M; Anguera A; Escribano J; Salas-Salvadó J
    Pediatrics; 2006 Sep; 118(3):e641-8. PubMed ID: 16950955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
    Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-bowel transit in patients with the irritable bowel syndrome.
    Hardy JG; Wood E; Clark AG; Reynolds JR
    Eur J Nucl Med; 1986; 11(10):393-6. PubMed ID: 3699063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple clinical assessment of colonic response to food.
    Bouchoucha M; Odinot JM; Devroede G; Landi B; Cugnenc PH; Barbier JP
    Int J Colorectal Dis; 1998; 13(5-6):217-22. PubMed ID: 9870164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a myoelectrical abnormality in the irritable colon syndrome?
    Taylor I; Darby C; Hammond P; Basu P
    Gut; 1978 May; 19(5):391-5. PubMed ID: 658769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
    Wittmann T; Fehér A; Rosztóczy A; Jánosi J
    Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current concepts in the management of the irritable bowel syndrome.
    Snape WJ
    Rev Gastroenterol Mex; 1994; 59(2):127-32. PubMed ID: 7991965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difficult defecation in constipated patients and its relationship to colonic disorders.
    Bouchoucha M; Devroede G; Bon C; Mary F; Bejou B; Benamouzig R
    Int J Colorectal Dis; 2016 Mar; 31(3):685-91. PubMed ID: 26861636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.
    Wong BS; Camilleri M; McKinzie S; Burton D; Graffner H; Zinsmeister AR
    Am J Gastroenterol; 2011 Dec; 106(12):2154-64. PubMed ID: 21876564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome?
    Cann PA; Read NW; Holdsworth CD
    Gut; 1984 Feb; 25(2):168-73. PubMed ID: 6319244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How many segments are necessary to characterize delayed colonic transit time?
    Bouchoucha M; Devroede G; Bon C; Raynaud JJ; Bejou B; Benamouzig R
    Int J Colorectal Dis; 2015 Oct; 30(10):1381-9. PubMed ID: 26062871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms and physiology in severe chronic constipation.
    Mertz H; Naliboff B; Mayer EA
    Am J Gastroenterol; 1999 Jan; 94(1):131-8. PubMed ID: 9934743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal motility in patients with irritable bowel syndrome studied by using radiopaque markers.
    Horikawa Y; Mieno H; Inoue M; Kajiyama G
    Scand J Gastroenterol; 1999 Dec; 34(12):1190-5. PubMed ID: 10636065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of the effects of dietary fiber on gastrointestinal transit.
    Hillemeier C
    Pediatrics; 1995 Nov; 96(5 Pt 2):997-9. PubMed ID: 7494680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.